| |
RX COMMUNICATIONS GROUP IS AWARDED AN HONORABLE MENTION FOR FINANCIAL/INVESTOR RELATIONS FROM PR NEWS
FOR INQUIRIES CONTACT
Pete Holmberg, Vice President Media Relations
Rx Communications Group, LLC
917-322-2164
pholmberg@rxir.com
FOR IMMEDIATE RELEASE
RX COMMUNICATIONS GROUP IS AWARDED AN HONORABLE MENTION FOR FINANCIAL/INVESTOR RELATIONS FROM PR NEWS
NEW YORK, NY, SEPTEMBER 25, 2003 – Rx Communications Group, LLC, a financial communications firm specializing in the life science and healthcare industries, today announced that the firm has received an Honorable Mention Award from PR News, as part of the PR News Platinum PR Awards 2003. The award was issued in the Financial/Investor Relations category, for the company’s work on behalf of Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC).
“We are delighted to have received this honor from such a distinguished industry organization. This Honorable Mention from PR News serves as further validation of the high quality work we continue to provide to our clients,” said Rhonda Chiger, Co-President of Rx Communications Group. “We are proud of our long-standing relationship with Genaissance Pharmaceuticals and our ability to have meaningfully contributed to the company’s investor relations strategy. Specifically, Rx Communications was instrumental in effectively communicating the company’s evolving messages throughout the year, and successfully steering management through a restructuring, while increasing the company’s valuation.”
The Platinum PR Awards Program is an annual competition in which PR News recognizes the most outstanding communications efforts of the past year. The investor relations program for Genaissance Pharmaceuticals included ongoing proactive investor communication and outreach, as well as issues management.
Melody A. Carey, Co-President of Rx Communications Group, said, “As our company approaches its third anniversary, we are truly pleased by the continued recognition we have received from our peers. This most recent accolade marks Rx Communications’ fourth industry acknowledgement this year. In addition to the PR News Honorable Mention Award, we received a Certificate of Excellence from the Silver SABRE (Superior Achievement in Branding and Reputation) Awards for our work on behalf of Switzerland-based client Syngenta AG (NYSE: SYT); we were presented with an Honorable Mention Award as part of the 2002 Magellan Awards Publicity Campaign Competition for the development of a media campaign for privately held ImpactRx, Inc.; and the company was selected as a finalist by PR Week for Boutique PR Agency of the Year.”
Rx Communications Group, LLC is a financial communications firm specializing in the life science and healthcare industries. Rx provides investor relations, media relations and corporate communications counsel to private and public companies, worldwide. The firm designs, implements and manages full-service programs, and handles transaction-oriented assignments. Rx executives are well versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and acquisitions. RxIR USAŇ is a service of Rx Communications geared toward non-U.S. listed public foreign companies seeking to reach U.S. investors. For more information about Rx Communications, visit the company’s website at http://www.RxIR.com.
|
|
